Skip to content

Arthur F. Guerrero, MD

NPI 1346211604ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Schertz, TX

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Schertz, Texas, trained at Uniformed Services Uhs Fe Hebert School of Med (class of 2004). Their prescriptions cost Medicare Part D more than their services did: $2,044,681 for 3,888 claims, against $319,739 paid for services in 2024. Novo Nordisk Inc was the largest of 26 companies reporting payments in 2025, $3,171 in all, mostly food and beverage.

Overview

NPI1346211604
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedJan 26, 2006
Last updated in NPPESJun 4, 2020
Certified by providerJun 4, 2020

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (TX)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients339
Services billed6,568 across 28 procedure codes
Paid by Medicare$319,739

Part D prescriptions in 2024

Prescriptions (claims)3,888 · 9,819 30-day fills
Patients320
Total drug cost$2,044,681
Generic share51% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniformed Services Uhs Fe Hebert School of Med
Graduation year2004
Medicare specialtyEndocrinology
Secondary specialtiesInternal Medicine
TelehealthOffers telehealth

Medical group

Hospital affiliation

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$3,171 · 171 payments from 26 companies
  • 2024$3,282 · 179 payments from 29 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$440.6226
Dexcom, Inc.$436.6627
Amgen Inc.$323.5719
Corcept Therapeutics$293.2120
Insulet Corporation$267.1716

What the 2025 payments were for

  • Food and Beverage$3,171 · 171 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in Schertz

All endocrinologists in Texas